#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#

Requirement for Ergosterol in V-ATPase Function Underlies Antifungal Activity of Azole Drugs


Ergosterol is an important constituent of fungal membranes. Azoles inhibit ergosterol biosynthesis, although the cellular basis for their antifungal activity is not understood. We used multiple approaches to demonstrate a critical requirement for ergosterol in vacuolar H+-ATPase function, which is known to be essential for fungal virulence. Ergosterol biosynthesis mutants of S. cerevisiae failed to acidify the vacuole and exhibited multiple vma phenotypes. Extraction of ergosterol from vacuolar membranes also inactivated V-ATPase without disrupting membrane association of its subdomains. In both S. cerevisiae and the fungal pathogen C. albicans, fluconazole impaired vacuolar acidification, whereas concomitant ergosterol feeding restored V-ATPase function and cell growth. Furthermore, fluconazole exacerbated cytosolic Ca2+ and H+ surges triggered by the antimicrobial agent amiodarone, and impaired Ca2+ sequestration in purified vacuolar vesicles. These findings provide a mechanistic basis for the synergy between azoles and amiodarone observed in vitro. Moreover, we show the clinical potential of this synergy in treatment of systemic fungal infections using a murine model of Candidiasis. In summary, we demonstrate a new regulatory component in fungal V-ATPase function, a novel role for ergosterol in vacuolar ion homeostasis, a plausible cellular mechanism for azole toxicity in fungi, and preliminary in vivo evidence for synergism between two antifungal agents. New insights into the cellular basis of azole toxicity in fungi may broaden therapeutic regimens for patient populations afflicted with systemic fungal infections.


Vyšlo v časopise: Requirement for Ergosterol in V-ATPase Function Underlies Antifungal Activity of Azole Drugs. PLoS Pathog 6(6): e32767. doi:10.1371/journal.ppat.1000939
Kategorie: Research Article
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.ppat.1000939

Souhrn

Ergosterol is an important constituent of fungal membranes. Azoles inhibit ergosterol biosynthesis, although the cellular basis for their antifungal activity is not understood. We used multiple approaches to demonstrate a critical requirement for ergosterol in vacuolar H+-ATPase function, which is known to be essential for fungal virulence. Ergosterol biosynthesis mutants of S. cerevisiae failed to acidify the vacuole and exhibited multiple vma phenotypes. Extraction of ergosterol from vacuolar membranes also inactivated V-ATPase without disrupting membrane association of its subdomains. In both S. cerevisiae and the fungal pathogen C. albicans, fluconazole impaired vacuolar acidification, whereas concomitant ergosterol feeding restored V-ATPase function and cell growth. Furthermore, fluconazole exacerbated cytosolic Ca2+ and H+ surges triggered by the antimicrobial agent amiodarone, and impaired Ca2+ sequestration in purified vacuolar vesicles. These findings provide a mechanistic basis for the synergy between azoles and amiodarone observed in vitro. Moreover, we show the clinical potential of this synergy in treatment of systemic fungal infections using a murine model of Candidiasis. In summary, we demonstrate a new regulatory component in fungal V-ATPase function, a novel role for ergosterol in vacuolar ion homeostasis, a plausible cellular mechanism for azole toxicity in fungi, and preliminary in vivo evidence for synergism between two antifungal agents. New insights into the cellular basis of azole toxicity in fungi may broaden therapeutic regimens for patient populations afflicted with systemic fungal infections.


Zdroje

1. CortiM

PalmeroD

EiguchiK

2009 Respiratory infections in immunocompromised patients. Curr Opin Pulm Med 15 209 217

2. NucciM

AnaissieE

2009 Fungal infections in hematopoietic stem cell transplantation and solid-organ transplantation–focus on aspergillosis. Clin Chest Med 30 295 306, vii

3. PappasPG

KauffmanCA

AndesD

BenjaminDKJr

CalandraTF

2009 Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis 48 503 535

4. HitchcockCA

DickinsonK

BrownSB

EvansEG

AdamsDJ

1990 Interaction of azole antifungal antibiotics with cytochrome P-450-dependent 14 alpha-sterol demethylase purified from Candida albicans. Biochem J 266 475 480

5. RyderNS

1985 Effect of allylamine antimycotic agents on fungal sterol biosynthesis measured by sterol side-chain methylation. J Gen Microbiol 131 1595 1602

6. MarcireauC

GuillotonM

KarstF

1990 In vivo effects of fenpropimorph on the yeast Saccharomyces cerevisiae and determination of the molecular basis of the antifungal property. Antimicrob Agents Chemother 34 989 993

7. MaxfieldFR

TabasI

2005 Role of cholesterol and lipid organization in disease. Nature 438 612 621

8. MunroS

2003 Lipid rafts: elusive or illusive? Cell 115 377 388

9. Heese-PeckA

PichlerH

ZanolariB

WatanabeR

DaumG

2002 Multiple functions of sterols in yeast endocytosis. Mol Biol Cell 13 2664 2680

10. JinH

McCafferyJM

GroteE

2008 Ergosterol promotes pheromone signaling and plasma membrane fusion in mating yeast. J Cell Biol 180 813 826

11. SchneiterR

BruggerB

SandhoffR

ZellnigG

LeberA

1999 Electrospray ionization tandem mass spectrometry (ESI-MS/MS) analysis of the lipid molecular species composition of yeast subcellular membranes reveals acyl chain-based sorting/remodeling of distinct molecular species en route to the plasma membrane. J Cell Biol 146 741 754

12. KatoM

WicknerW

2001 Ergosterol is required for the Sec18/ATP-dependent priming step of homotypic vacuole fusion. Embo J 20 4035 4040

13. ThorpeGW

FongCS

AlicN

HigginsVJ

DawesIW

2004 Cells have distinct mechanisms to maintain protection against different reactive oxygen species: oxidative-stress-response genes. Proc Natl Acad Sci U S A 101 6564 6569

14. UmebayashiK

NakanoA

2003 Ergosterol is required for targeting of tryptophan permease to the yeast plasma membrane. J Cell Biol 161 1117 1131

15. GuptaSS

TonVK

BeaudryV

RulliS

CunninghamK

2003 Antifungal activity of amiodarone is mediated by disruption of calcium homeostasis. J Biol Chem 278 28831 28839

16. CourchesneWE

2002 Characterization of a novel, broad-based fungicidal activity for the antiarrhythmic drug amiodarone. J Pharmacol Exp Ther 300 195 199

17. MaresovaL

MuendS

ZhangYQ

SychrovaH

RaoR

2009 Membrane hyperpolarization drives cation influx and fungicidal activity of amiodarone. J Biol Chem 284 2795 2802

18. ZhangYQ

RaoR

2007 Global disruption of cell cycle progression and nutrient response by the antifungal agent amiodarone. J Biol Chem 282 37844 37853

19. MuendS

RaoR

2008 Fungicidal activity of amiodarone is tightly coupled to calcium influx. FEMS Yeast Res 8 425 431

20. ChungJH

LesterRL

DicksonRC

2003 Sphingolipid requirement for generation of a functional v1 component of the vacuolar ATPase. J Biol Chem 278 28872 28881

21. AliR

BrettCL

MukherjeeS

RaoR

2004 Inhibition of sodium/proton exchange by a Rab-GTPase-activating protein regulates endosomal traffic in yeast. J Biol Chem 279 4498 4506

22. BagnatM

KeranenS

ShevchenkoA

SimonsK

2000 Lipid rafts function in biosynthetic delivery of proteins to the cell surface in yeast. Proc Natl Acad Sci U S A 97 3254 3259

23. LeeMC

HamamotoS

SchekmanR

2002 Ceramide biosynthesis is required for the formation of the oligomeric H+-ATPase Pma1p in the yeast endoplasmic reticulum. J Biol Chem 277 22395 22401

24. PerlinDS

HarrisSL

Seto-YoungD

HaberJE

1989 Defective H(+)-ATPase of hygromycin B-resistant pma1 mutants fromSaccharomyces cerevisiae. J Biol Chem 264 21857 21864

25. KanePM

2007 The long physiological reach of the yeast vacuolar H+-ATPase. J Bioenerg Biomembr 39 415 421

26. WatsonPF

RoseME

EllisSW

EnglandH

KellySL

1989 Defective sterol C5-6 desaturation and azole resistance: a new hypothesis for the mode of action of azole antifungals. Biochem Biophys Res Commun 164 1170 1175

27. KellySL

LambDC

KellyDE

ManningNJ

LoefflerJ

1997 Resistance to fluconazole and cross-resistance to amphotericin B in Candida albicans from AIDS patients caused by defective sterol delta5,6-desaturation. FEBS Lett 400 80 82

28. LiY

PrinzWA

2004 ATP-binding cassette (ABC) transporters mediate nonvesicular, raft-modulated sterol movement from the plasma membrane to the endoplasmic reticulum. J Biol Chem 279 45226 45234

29. WilcoxLJ

BalderesDA

WhartonB

TinkelenbergAH

RaoG

2002 Transcriptional profiling identifies two members of the ATP-binding cassette transporter superfamily required for sterol uptake in yeast. J Biol Chem 277 32466 32472

30. PoltermannS

NguyenM

GuntherJ

WendlandJ

HartlA

2005 The putative vacuolar ATPase subunit Vma7p of Candida albicans is involved in vacuole acidification, hyphal development and virulence. Microbiology 151 1645 1655

31. JiaN

Arthington-SkaggsB

LeeW

PiersonCA

LeesND

2002 Candida albicans sterol C-14 reductase, encoded by the ERG24 gene, as a potential antifungal target site. Antimicrob Agents Chemother 46 947 957

32. BrettCL

TukayeDN

MukherjeeS

RaoR

2005 The yeast endosomal Na+K+/H+ exchanger Nhx1 regulates cellular pH to control vesicle trafficking. Mol Biol Cell 16 1396 1405

33. YadavJ

MuendS

ZhangY

RaoR

2007 A phenomics approach in yeast links proton and calcium pump function in the Golgi. Mol Biol Cell 18 1480 1489

34. SerranoR

BernalD

SimonE

ArinoJ

2004 Copper and iron are the limiting factors for growth of the yeast Saccharomyces cerevisiae in an alkaline environment. J Biol Chem 279 19698 19704

35. KawahataM

MasakiK

FujiiT

IefujiH

2006 Yeast genes involved in response to lactic acid and acetic acid: acidic conditions caused by the organic acids in Saccharomyces cerevisiae cultures induce expression of intracellular metal metabolism genes regulated by Aft1p. FEMS Yeast Res 6 924 936

36. PerzovN

Padler-KaravaniV

NelsonH

NelsonN

2002 Characterization of yeast V-ATPase mutants lacking Vph1p or Stv1p and the effect on endocytosis. J Exp Biol 205 1209 1219

37. EricksonT

LiuL

GueyikianA

ZhuX

GibbonsJ

2001 Multiple virulence factors of Cryptococcus neoformans are dependent on VPH1. Mol Microbiol 42 1121 1131

38. KanePM

2000 Regulation of V-ATPases by reversible disassembly. FEBS Lett 469 137 141

39. LafourcadeC

SoboK

Kieffer-JaquinodS

GarinJ

van der GootFG

2008 Regulation of the V-ATPase along the endocytic pathway occurs through reversible subunit association and membrane localization. PLoS One 3 e2758

40. YoshinakaK

KumanogohH

NakamuraS

MaekawaS

2004 Identification of V-ATPase as a major component in the raft fraction prepared from the synaptic plasma membrane and the synaptic vesicle of rat brain. Neurosci Lett 363 168 172

41. DixonN

PaliT

KeeTP

BallS

HarrisonMA

2008 Interaction of spin-labeled inhibitors of the vacuolar H+-ATPase with the transmembrane Vo-sector. Biophys J 94 506 514

42. PaliT

DixonN

KeeTP

MarshD

2004 Incorporation of the V-ATPase inhibitors concanamycin and indole pentadiene in lipid membranes. Spin-label EPR studies. Biochim Biophys Acta 1663 14 18

43. MichelangeliF

EastJM

LeeAG

1990 Structural effects on the interaction of sterols with the (Ca2++Mg2+)-ATPase. Biochim Biophys Acta 1025 99 108

44. CorneliusF

2001 Modulation of Na,K-ATPase and Na-ATPase activity by phospholipids and cholesterol. I. Steady-state kinetics. Biochemistry 40 8842 8851

45. AbeF

UsuiK

HirakiT

2009 Fluconazole modulates membrane rigidity, heterogeneity, and water penetration into the plasma membrane in Saccharomyces cerevisiae. Biochemistry 48 8494 8504

46. LambD

KellyD

KellyS

1999 Molecular aspects of azole antifungal action and resistance. Drug Resist Updat 2 390 402

47. KobayashiD

KondoK

UeharaN

OtokozawaS

TsujiN

2002 Endogenous reactive oxygen species is an important mediator of miconazole antifungal effect. Antimicrob Agents Chemother 46 3113 3117

48. SwamyKM

KimHN

SohJH

KimY

KimSJ

2009 Manipulation of fluorescent and colorimetric changes of fluorescein derivatives and applications for sensing silver ions. Chem Commun (Camb) 1234 1236

49. BenaimG

SandersJM

Garcia-MarchanY

ColinaC

LiraR

2006 Amiodarone has intrinsic anti-Trypanosoma cruzi activity and acts synergistically with posaconazole. J Med Chem 49 892 899

50. GuoQ

SunS

YuJ

LiY

CaoL

2008 Synergistic activity of azoles with amiodarone against clinically resistant Candida albicans tested by chequerboard and time-kill methods. J Med Microbiol 57 457 462

51. AfeltraJ

VitaleRG

MoutonJW

VerweijPE

2004 Potent synergistic in vitro interaction between nonantimicrobial membrane-active compounds and itraconazole against clinical isolates of Aspergillus fumigatus resistant to itraconazole. Antimicrob Agents Chemother 48 1335 1343

52. GamarraS

RochaEM

ZhangYQ

ParkS

RaoR

2010 Mechanism of the Synergistic Effect of Amiodarone and Fluconazole in Candida albicans. Antimicrob Agents Chemother

53. BienCM

ChangYC

NesWD

Kwon-ChungKJ

EspenshadePJ

2009 Cryptococcus neoformans Site-2 protease is required for virulence and survival in the presence of azole drugs. Mol Microbiol 74 672 690

54. RobertsCJ

RaymondCK

YamashiroCT

StevensTH

1991 Methods for studying the yeast vacuole. Methods Enzymol 194 644 661

55. PerlinDS

BrownCL

HaberJE

1988 Membrane potential defect in hygromycin B-resistant pma1 mutants of Saccharomyces cerevisiae. J Biol Chem 263 18118 18122

Štítky
Hygiena a epidemiológia Infekčné lekárstvo Laboratórium

Článok vyšiel v časopise

PLOS Pathogens


2010 Číslo 6
Najčítanejšie tento týždeň
Najčítanejšie v tomto čísle
Kurzy

Zvýšte si kvalifikáciu online z pohodlia domova

Aktuální možnosti diagnostiky a léčby litiáz
nový kurz
Autori: MUDr. Tomáš Ürge, PhD.

Všetky kurzy
Prihlásenie
Zabudnuté heslo

Zadajte e-mailovú adresu, s ktorou ste vytvárali účet. Budú Vám na ňu zasielané informácie k nastaveniu nového hesla.

Prihlásenie

Nemáte účet?  Registrujte sa

#ADS_BOTTOM_SCRIPTS#